> ## Content Index
> Fetch the complete content index at: https://www.fdaweb.com/llms.txt
> Use this file to discover other available public pages before exploring further.

# Latest FDA Warning Letter
- URL: https://www.fdaweb.com/latest-fda-warning-letter-11/
- Published: 2021-01-12T12:00:00.000Z
- Updated: 2026-09-14T16:42:11.000Z
- Author: David McFarland
- Tags: FDA Policy/General, #legacy-id-D5148433

FDA has posted its latest batch of Warning Letters that includes one medical product company. It can be accessed by clicking on the link following the summary below:  

**Bonagens**, Duluth, GA (11/17): FDA recently reviewed the firm’s Web site ([*https://bonagensinc.com*](https://bonagensinc.com/?ref=fdaweb.com)) and determined that its products “Anti-Aging Supports,” “Cholesterol & Diabetes Control,” “Gout Control,” “Hypertension Control,” “Liver Supports,” “Lungs Supports,” “Vita-V for Men,” and “Weight Lost,” are new drugs because their claims suggest they are intended for use in the cure, mitigation, treatment, or prevention of disease. The letter told the company to take prompt action to correct the violations cited. To view the letter, click [here](https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/bonagens-609905-11172020?ref=fdaweb.com).